Development of Anemia
anemia
ANEMIA
Among participants without anemia, a significantly smaller proportion of participants in the testosterone group developed anemia postrandomization compared with placebo group at 6 months (143 of 1997 [7.2%] vs 203 of 1958 [10.4%]), 12 months (137 of 1934 [7.1%] vs 171 of 1894 [9.0%]), 24 months (174 of 1746 [10.0%] vs 207 of 1677 [12.3%]), 36 months (135 of 1347 [10.0%] vs 167 of 1300 [12.9%]), and 48 months (51 of 570 [9.0%] vs 51 of 499 [10.2%]) (omnibus test 